NHIA has compiled product shortage recommendations to help clinicians manage patient care and conserve prefilled NS syringe supplies during this time when they may not be readily available.
Menu
CMS recently issued a report which summarizes utilization trends for the Medicare Part B home infusion therapy (HIT) services benefit indicating the benefit has failed to draw sufficient participation from providers to ensure equitable access to beneficiaries across the U.S.
NHIA has developed product shortage recommendations to help clinicians manage patients during this time when diluents, and small and large volume parenteral solutions may not be readily available.